annual EBITDA:
-$397.33M-$1.89B(-126.65%)Summary
- As of today (May 29, 2025), BNTX annual EBITDA is -$397.33 million, with the most recent change of -$1.89 billion (-126.65%) on December 31, 2024.
- During the last 3 years, BNTX annual EBITDA has fallen by -$18.15 billion (-102.24%).
- BNTX annual EBITDA is now -102.24% below its all-time high of $17.75 billion, reached on December 31, 2021.
Performance
BNTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$387.96M-$882.99M(-178.37%)Summary
- As of today (May 29, 2025), BNTX quarterly EBITDA is -$387.96 million, with the most recent change of -$882.99 million (-178.37%) on March 1, 2025.
- Over the past year, BNTX quarterly EBITDA has dropped by -$74.26 million (-23.67%).
- BNTX quarterly EBITDA is now -106.84% below its all-time high of $5.67 billion, reached on March 31, 2022.
Performance
BNTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$466.82M-$74.26M(-18.92%)Summary
- As of today (May 29, 2025), BNTX TTM EBITDA is -$466.82 million, with the most recent change of -$74.26 million (-18.92%) on March 1, 2025.
- Over the past year, BNTX TTM EBITDA has dropped by -$837.31 million (-226.00%).
- BNTX TTM EBITDA is now -102.19% below its all-time high of $21.35 billion, reached on March 31, 2022.
Performance
BNTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -126.7% | -23.7% | -226.0% |
| 3 y3 years | -102.2% | -106.8% | -102.2% |
| 5 y5 years | -146.8% | -691.8% | -174.6% |
BNTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.2% | at low | -106.8% | +51.9% | -102.2% | at low |
| 5 y | 5-year | -102.2% | at low | -106.8% | +51.9% | -102.2% | at low |
| alltime | all time | -102.2% | at low | -106.8% | +51.9% | -102.2% | at low |
BNTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$387.96M(-178.4%) | -$466.82M(+18.9%) |
| Dec 2024 | -$397.33M(-126.6%) | $495.03M(+113.2%) | -$392.55M(+362.6%) |
| Sep 2024 | - | $232.17M(-128.8%) | -$84.85M(+280.7%) |
| Jun 2024 | - | -$806.06M(+157.0%) | -$22.29M(-106.0%) |
| Mar 2024 | - | -$313.69M(-139.1%) | $370.49M(-75.5%) |
| Dec 2023 | $1.49B(-89.2%) | $802.73M(+172.4%) | $1.51B(-62.1%) |
| Sep 2023 | - | $294.73M(-171.3%) | $3.98B(-35.6%) |
| Jun 2023 | - | -$413.28M(-150.1%) | $6.19B(-28.7%) |
| Mar 2023 | - | $824.97M(-74.8%) | $8.68B(-35.8%) |
| Dec 2022 | $13.81B(-22.2%) | $3.28B(+31.0%) | $13.53B(-12.9%) |
| Sep 2022 | - | $2.50B(+20.0%) | $15.53B(-16.3%) |
| Jun 2022 | - | $2.08B(-63.3%) | $18.56B(-13.0%) |
| Mar 2022 | - | $5.67B(+7.3%) | $21.35B(+20.8%) |
| Dec 2021 | $17.75B | $5.28B(-4.4%) | $17.67B(+39.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $5.53B(+13.5%) | $12.65B(+83.6%) |
| Jun 2021 | - | $4.87B(+144.0%) | $6.89B(+256.2%) |
| Mar 2021 | - | $2.00B(+665.3%) | $1.94B(-1868.1%) |
| Dec 2020 | -$120.03M(-25.4%) | $260.76M(-212.5%) | -$109.44M(-74.2%) |
| Sep 2020 | - | -$231.78M(+159.2%) | -$423.89M(+96.6%) |
| Jun 2020 | - | -$89.43M(+82.5%) | -$215.56M(+26.8%) |
| Mar 2020 | - | -$49.00M(-8.7%) | -$169.98M(+7.2%) |
| Dec 2019 | -$160.98M(+469.1%) | -$53.69M(+129.0%) | -$158.55M(+64.0%) |
| Sep 2019 | - | -$23.45M(-46.5%) | -$96.67M(+4.9%) |
| Jun 2019 | - | -$43.85M(+16.7%) | -$92.18M(+90.7%) |
| Mar 2019 | - | -$37.57M(-558.5%) | -$48.33M(+349.0%) |
| Dec 2018 | -$28.29M(-66.6%) | $8.19M(-143.2%) | -$10.76M(-43.2%) |
| Sep 2018 | - | -$18.96M | -$18.96M |
| Dec 2017 | -$84.60M | - | - |
FAQ
- What is BioNTech SE annual EBITDA?
- What is the all time high annual EBITDA for BioNTech SE?
- What is BioNTech SE annual EBITDA year-on-year change?
- What is BioNTech SE quarterly EBITDA?
- What is the all time high quarterly EBITDA for BioNTech SE?
- What is BioNTech SE quarterly EBITDA year-on-year change?
- What is BioNTech SE TTM EBITDA?
- What is the all time high TTM EBITDA for BioNTech SE?
- What is BioNTech SE TTM EBITDA year-on-year change?
What is BioNTech SE annual EBITDA?
The current annual EBITDA of BNTX is -$397.33M
What is the all time high annual EBITDA for BioNTech SE?
BioNTech SE all-time high annual EBITDA is $17.75B
What is BioNTech SE annual EBITDA year-on-year change?
Over the past year, BNTX annual EBITDA has changed by -$1.89B (-126.65%)
What is BioNTech SE quarterly EBITDA?
The current quarterly EBITDA of BNTX is -$387.96M
What is the all time high quarterly EBITDA for BioNTech SE?
BioNTech SE all-time high quarterly EBITDA is $5.67B
What is BioNTech SE quarterly EBITDA year-on-year change?
Over the past year, BNTX quarterly EBITDA has changed by -$74.26M (-23.67%)
What is BioNTech SE TTM EBITDA?
The current TTM EBITDA of BNTX is -$466.82M
What is the all time high TTM EBITDA for BioNTech SE?
BioNTech SE all-time high TTM EBITDA is $21.35B
What is BioNTech SE TTM EBITDA year-on-year change?
Over the past year, BNTX TTM EBITDA has changed by -$837.31M (-226.00%)